ZHANG, XIAOKUI,KANG, LIN,HEIDARAN, MOHAMMAD,JASKO, STEVEN,ZEITLIN, ANDY,PAL, AJAI,HARIRI, ROBERT J.
申请号：
PL10722830
公开号：
PL2411506T3
申请日:
2010.03.26
申请国别(地区):
PL
年份:
2019
代理人:
摘要：
Provided herein are placenta-derived intermediate natural killer cells for use in methods of suppressing tumor cell proliferation, or treating individuals having cancer or a viral infection. The method comprises contacting the tumor cells, or administering to the individual, placental perfusate, placental perfusate cells, or natural killer cells, e.g., placenta-derived intermediate natural killer cells. The method may further comprises administering an immunomodulatory compound or thalidomide.
